YIFAN PHARMACEUTICAL CO (SZSE:002019) Total Stockholders Equity : ¥8,407 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Total Stockholders Equity?

YIFAN PHARMACEUTICAL CO's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥8,407 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. YIFAN PHARMACEUTICAL CO's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.86. The ratio of a company's debt over equity can be used to measure how leveraged this company is. YIFAN PHARMACEUTICAL CO's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.24.

YIFAN PHARMACEUTICAL CO Total Stockholders Equity Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Total Stockholders Equity Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

7,499.56

8,430.50

8,535.79

8,812.04

8,275.63

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															8,859.48	8,981.73	8,985.61	8,275.63	8,407.49

YIFAN PHARMACEUTICAL CO (SZSE:002019) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

YIFAN PHARMACEUTICAL CO's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(8407.491	-	0)	/	1226.02
	=	6.86

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

YIFAN PHARMACEUTICAL CO's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1235.666	+	776.657)	/	8407.491
	=	0.24

YIFAN PHARMACEUTICAL CO Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines